STAAR Surgical CompanySTAANASDAQ
LOADING
|||

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
13 analysts·Moderate coverage
15%
Rating Distribution
Strong Buy
00%
Buy
215%
Hold
1077%
Sell
18%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 24% higher.

Bear Case
$13.00
-31%
Consensus
$23.44
+24%
Bull Case
$30.75
+62%
Price Range13 analysts
Low
Consensus
High
$13.00
$30.75
Current Target
Current Price
$18.95
Upside to Target
$4.49

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 16, 2026Morgan Stanley
Staar Surgical resumed with an Underweight at Morgan Stanley
Target:$13.00
-38.0%from $20.97
Jan 15, 2026Canaccord Genuity
STAAR Surgical (STAA) PT Lowered to $22 at Canaccord Genuity
Target:$22.00
+4.7%from $21.02
Dec 10, 2025Wells Fargo
Staar Surgical price target raised to $30.75 from $28 at Wells Fargo
Target:$30.75
+21.2%from $25.38
Dec 9, 2025Canaccord Genuity
STAAR Surgical (STAA) PT Raised to $30.75 at Canaccord Genuity
Target:$30.75
+18.8%from $25.89
Oct 21, 2025Canaccord Genuity
Canaccord Genuity Reiterates Hold Rating on STAAR Surgical (STAA)
Target:$28.00
+10.6%from $25.32
Aug 7, 2025Stifel Nicolaus
Staar Surgical downgraded to Hold from Buy at Stifel
Target:$28.00
+4.1%from $26.90
Jun 11, 2024BTIG
BTIG Upgrades STAAR Surgical (STAA) to Buy
Target:$46.00
+20.8%from $38.07
Apr 9, 2024Jefferies
STAAR Surgical (STAA) PT Raised to $60 at Jefferies, 'Strong Start to 2024'
Target:$60.00
+18.6%from $50.59
Apr 8, 2024Canaccord Genuity
STAAR Surgical (STAA) PT Raised to $46 at Canaccord Genuity
Target:$46.00
-5.5%from $48.68
Apr 4, 2024William Blair
Staar Surgical upgraded to Outperform after Q1 beat at William Blair
Target:$45.03
-1.1%from $45.54
Jan 11, 2023Stephens
STAAR Surgical (STAA) Stock Receives A $85 Price Target
Target:$85.00
+24.0%from $68.56
Sep 23, 2022Truist Financial
Truist Securities Maintains Buy on AAR, Lowers Price Target to $48
Target:$48.00
-33.3%from $71.93
Sep 23, 2022RBC Capital
RBC Capital Maintains Outperform on AAR, Lowers Price Target to $52
Target:$52.00
-29.0%from $73.19
Jul 19, 2022Truist Financial
Truist Securities Maintains Buy on AAR, Lowers Price Target to $54
Target:$54.00
-27.7%from $74.65
Apr 26, 2022Canaccord Genuity
Canaccord Genuity Maintains Buy on Staar Surgical, Raises Price Target to $89
Target:$89.00
+50.8%from $59.02
Mar 23, 2022Truist Financial
Analysts Bump Up AAR's Price Target Post Q3 Results
Target:$58.00
-19.4%from $71.96